# US 2016/0242686 A1 · Fiberoptic probe for measuring tissue oxygenation and method for using same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0242686 A1
- Document ID: US20160242686A1
- Status: Published application
- Kind: A1
- Application number: 15/147,718
- Filed: 2016-05-05
- Published: 2016-08-25
- Earliest claimed: 2010-01-25
- Assignees: Oregon Health & Science University
- Applicants: Oregon Health & Science University
- Inventors: Dan Gareau; Steve Jaques; John Hunter
- Web page: https://patentgrep.com/patent/US20160242686A1

## CPC

- A61B 5/14552: {Details of sensors specially adapted therefor}
- A61B 5/0075: {by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy (A61B5/0071 takes precedence)}
- A61B 5/1459: invasive, e.g. introduced into the body by a catheter
- A61B 2562/0233: Special features of optical sensors or probes classified in A61B5/00
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

Embodiments herein relate to the field of medical monitoring, and, more specifically, to a fiberoptic probe for monitoring tissue oxygenation and a method for using such a probe. A non-invasive method of measuring tissue oxygenation includes, in some embodiments, illuminating a tissue surface with a first fiberoptic fiber, receiving light from the tissue surface with a second fiberoptic fiber, measuring the absorption spectra of oxy- and deoxy-hemoglobin in the light, and calculating a tissue oxygenation value based on the absorption spectra.

## Claims

### Claim 1

A fiberoptic device, comprising:
a probe comprising at least a first fiberoptic fiber and a second fiberoptic fiber, wherein the first and second fiberoptic fibers terminate at or near a surface of the probe;
a visible wavelength light source coupled to the first fiberoptic fiber; and
a spectrometer coupled to the second fiberoptic fiber and configured to measure light transport in tissue adjacent to the surface of the probe.

### Claim 2 (depends on 1)

The fiberoptic device of claim 1, further comprising a computing device electrically coupled to the spectrometer, wherein the computing device is configured to generate a tissue oxygenation value and total blood volume content based on the light transport measured by the spectrometer.

### Claim 3 (depends on 2)

The fiberoptic device of claim 2, wherein the computing device is configured to generate a tissue oxygenation value using absorption spectra of oxy- and deoxy-hemoglobin and a scattering spectrum of bulk tissue.

### Claim 4 (depends on 3)

The fiberoptic device of claim 3, wherein the tissue oxygenation value comprises an estimate of the blood volume fraction and oxygen saturation of hemoglobin HbO2/(Hb+HbO2) in mixed arterio-venous vasculature of bulk tissue.

### Claim 5 (depends on 1)

The fiberoptic device of claim 1, wherein the surface of the probe is a distal tip surface.

### Claim 6 (depends on 1)

The fiberoptic device of claim 1, wherein the surface of the probe is a side surface.

### Claim 7 (depends on 1)

The fiberoptic device of claim 1, further comprising a plastic probe tip housing that houses at least part of the first and second fiberoptic fibers.

### Claim 8 (depends on 1)

The fiberoptic device of claim 1, wherein the first and second fiberoptic fibers are at least partially disposed in a UV-cured optical waveguide.

### Claim 9 (depends on 8)

The fiberoptic device of claim 8, further comprising one or more mirrored surfaces disposed in the UV-cured optical waveguide and configured to redirect light.

### Claim 10 (depends on 9)

The fiberoptic device of claim 9, wherein the one or more mirrored surfaces comprise one or more cylindrical metal components having 45° angled mirrored surfaces.

### Claim 11 (depends on 1)

The fiberoptic device of claim 1, wherein the first and second fiberoptic fibers are spaced from about 2 mm to about 4 mm apart at the surface of the probe.

### Claim 12 (depends on 1)

The fiberoptic device of claim 1, wherein the first and second fiberoptic fibers are spaced from about 2.5 mm to about 3.5 mm apart at the surface of the probe.

### Claim 13 (depends on 1)

The fiberoptic device of claim 1, wherein the first and second fiberoptic fibers are spaced about 3 mm apart at the surface of the probe.

### Claim 14 (depends on 1)

The fiberoptic device of claim 1, further comprising a cable that encloses at least a portion of the fiberoptic fibers.

### Claim 15 (depends on 1)

The fiberoptic device of claim 1, further comprising a suture substrate for securing the probe surface against a tissue.

### Claim 16 (depends on 15)

The fiberoptic device of claim 15, wherein the suture substrate comprises a UV-cured optical waveguide.

### Claim 17 (depends on 16)

The fiberoptic device of claim 16, wherein the UV-cured waveguide is configured to correspond in shape and/or size to one or more features of a surgical site.

### Claim 18 (depends on 1)

The fiberoptic device of claim 1, wherein the spectrometer is coupled to the second fiberoptic fiber by multiple-around-one circular fibers.

### Claim 19 (depends on 1)

The fiberoptic device of claim 1, further comprising an outermost biocompatible coating disposed on at least a portion of the probe.

### Claim 20 (depends on 19)

The fiberoptic device of claim 19, wherein the biocompatible coating comprises silicone rubber.

### Claim 21

A method of measuring tissue oxygenation, comprising:
illuminating a tissue surface with a first fiberoptic fiber;
receiving light from the tissue surface with a second fiberoptic fiber, wherein the light received by the second fiberoptic fiber comprises a visible wavelength range tissue spectrum;
measuring the absorption spectra of oxy- and deoxy-hemoglobin in the light; and
calculating a tissue oxygenation value based on fitting the tissue spectrum in the visible wavelength range to the absorption spectra of oxy- and deoxy-hemoglobin.

### Claim 22 (depends on 21)

The method of claim 21, wherein calculating a tissue oxygenation value based on fitting the tissue spectrum in the visible wavelength range to the absorption spectra of oxy- and deoxy-hemoglobin comprises estimating a blood volume fraction and an oxygen saturation of hemoglobin HbO2/(Hb+HbO2) in mixed arterio-venous vasculature.

### Claim 23 (depends on 21)

The method of claim 21, further comprising inserting the probe adjacent to the tissue.

### Claim 24 (depends on 23)

The method of claim 23, wherein inserting the probe comprises performing laparoscopic surgery on a subject.

### Claim 25 (depends on 23)

The method of claim 23, wherein inserting the probe comprises performing cosmetic surgery on a subject.

### Claim 26 (depends on 19)

The method of claim 19, wherein the tissue comprises an anastomosis, a repositioned flap in cosmetic surgery, or an effected distal region in vascular surgery.

### Claim 27 (depends on 21)

The method of claim 21, wherein the wavelength of the light is from about 480 to about 700 nm.

### Claim 28 (depends on 21)

The method of claim 21, wherein the light received by the second fiberoptic fiber comprises a diffuse reflectance spectrum.
